We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Fabrinet
FN
$15.6B
| $2.35M | ﹤0.01% |
82,012
+12,470
| +18% | +$413K |
|
|
FNSR
1527
DELISTED
Finisar Corp
FNSR
| $2.35M | ﹤0.01% |
115,682
-18,512
| -14% | -$385K |
|
1528
Universal Insurance Holdings
UVE
$1.22B
| $2.35M | ﹤0.01% |
86,001
+8,591
| +11% | +$216K |
|
|
NAV
1529
DELISTED
Navistar International
NAV
| $2.35M | ﹤0.01% |
54,850
-8,448
| -13% | -$351K |
|
1530
E.W. Scripps
SSP
$257M
| $2.35M | ﹤0.01% |
150,363
+16,182
| +12% | +$262K |
|
1531
Tenet Healthcare
THC
$20.5B
| $2.35M | ﹤0.01% |
154,819
+9,078
| +6% | +$128K |
|
|
DO
1532
DELISTED
Diamond Offshore Drilling
DO
| $2.35M | ﹤0.01% |
126,268
-11,160
| -8% | -$181K |
|
|
JCP
1533
DELISTED
J.C. Penney Company, Inc.
JCP
| $2.35M | ﹤0.01% |
741,981
+100,117
| +16% | +$322K |
|
|
LABL
1534
DELISTED
Multi-Color Corp
LABL
| $2.34M | ﹤0.01% |
31,287
+4,722
| +18% | +$366K |
|
1535
ePlus
PLUS
$2.42B
| $2.33M | ﹤0.01% |
62,062
+9,694
| +19% | +$408K |
|
|
LHCG
1536
DELISTED
LHC Group LLC
LHCG
| $2.33M | ﹤0.01% |
38,021
+5,371
| +16% | +$355K |
|
1537
Kulicke & Soffa
KLIC
$4.67B
| $2.33M | ﹤0.01% |
95,586
+35,267
| +58% | +$841K |
|
1538
Insmed
INSM
$21.4B
| $2.33M | ﹤0.01% |
74,574
-10,798
| -13% | -$319K |
|
|
WLL
1539
DELISTED
Whiting Petroleum Corporation
WLL
| $2.32M | ﹤0.01% |
1,169
+78
| +7% | +$137K |
|
|
ACOR
1540
DELISTED
Acorda Therapeutics
ACOR
| $2.32M | ﹤0.01% |
900
+123
| +16% | +$350K |
|
1541
Cleveland-Cliffs
CLF
$6.57B
| $2.32M | ﹤0.01% |
321,201
-76,908
| -19% | -$512K |
|
1542
Rayonier Advanced Materials
RYAM
$604M
| $2.32M | ﹤0.01% |
113,244
+25,497
| +29% | +$428K |
|
|
MNDT
1543
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $2.31M | ﹤0.01% |
162,955
-870
| -0.5% | -$13.2K |
|
1544
Etsy
ETSY
$7.75B
| $2.31M | ﹤0.01% |
113,068
-17,590
| -13% | -$310K |
|
|
AVTA
1545
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.31M | ﹤0.01% |
104,517
+16,797
| +19% | +$374K |
|
1546
CEVA Inc
CEVA
$910M
| $2.31M | ﹤0.01% |
50,034
+6,951
| +16% | +$319K |
|
1547
Chord Energy
CHRD
$7.9B
| $2.31M | ﹤0.01% |
274,543
-91,991
| -25% | -$848K |
|
1548
Iridium Communications
IRDM
$5.02B
| $2.3M | ﹤0.01% |
194,850
+26,209
| +16% | +$303K |
|
1549
M/I Homes
MHO
$3.74B
| $2.3M | ﹤0.01% |
66,758
+12,945
| +24% | +$423K |
|
1550
Columbia Sportswear
COLM
$3.04B
| $2.29M | ﹤0.01% |
31,927
-5,300
| -14% | -$348K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.